
Location:
United States
Genres:
Science Podcasts
Description:
Core EM Emergency Medicine Podcast
Language:
English
Website:
https://coreem.net/
Episodes
Episode 222: Local Anesthetic Systemic Toxicity (LAST)
4/7/2026
We discuss this ominous complication of providing local anesthesia.
Hosts:
Elaine Jonas, MD
Brian Gilberti, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/LAST.mp3
Download Leave a Comment Tags: Critical Care, Toxicology
Show Notes
I. Pathophysiology & Mechanisms
Definition: Systemic toxicity secondary to local anesthetic (LA) via accidental intravascular injection or excessive systemic absorption.
Threshold: Occurs when plasma concentration exceeds the safety threshold for cardiac and neural tissue.
Agent Profile: Bupivacaine (High Risk)
Highly lipophilic with high protein binding.
βFast-on, Slow-offβ Kinetics: Strong Na+ channel binding with extremely slow dissociation during diastole.
Myocardial Depression: Direct inhibition of Ca2+ release from the sarcoplasmic reticulum, impairing contractility.
Low CC:CNS Ratio: The dose required for cardiac collapse is very close to the dose that triggers seizures (narrow safety margin).
Contributing Factors:
Acidosis/Hypercapnia: Increases the fraction of free drug and promotes ion trapping in the brain/heart; shifts the LA-binding curve toward higher toxicity.
Hypoxemia: Exacerbates myocardial depression and lowers seizure threshold.
II. Risk Assessment & Prevention
Patient-Specific Risk Factors
Extremes of Age: Neonates (low Ξ±-1-acid glycoprotein) and elderly (reduced clearance).
Body Composition: Low muscle mass/frailty (decreased volume of distribution).
Organ Dysfunction:
Hepatic: Reduced metabolism of amide LAs.
Renal: Accumulation of metabolites; risk of metabolic acidosis lowering seizure threshold.
Cardiac: Reduced cardiac output slows hepatic delivery/clearance; heart failure patients are more sensitive to Na+ channel blockade.
Pregnancy: Increased sensitivity to cardiotoxicity.
Procedural Risk Factors
Vascularity of Site (Highest to Lowest Risk):
Intercostal blocks (highest absorption rate).
Caudal/Epidural.
Interfascial plane blocks (e.g., TAP block).
Psoas compartment/Sciatic.
Brachial plexus.
Technique: Large volume infiltration, lack of ultrasound, lack of incremental injection.
Prevention Mandates
Weight-Based Dosing:
Lidocaine (Plain): Max 4.5 mg/kg.
Lidocaine (with Epi): Max 7 mg/kg.
Bupivacaine: Max 2.5β3 mg/kg.
Incremental Injection: 3β5 mL aliquots with frequent aspiration.
Intravascular Marker: Use Epinephrine (1:200,000) to detect accidental IV placement (HR increase >10 bpmor SBP increase >15 mmHg).
III. Clinical Presentation
Neurologic Phase (Early to Late)
Subjective: Metallic taste, tinnitus, circumoral numbness/tingling.
Objective: Visual disturbances, agitation, confusion, tremors.
Critical: Generalized tonic-clonic seizures, rapid progression to CNS depression, coma, and apnea.
Note: Early phases are often masked in patients receiving midazolam or propofol.
Cardiovascular Phase
Initial: Hypertension and tachycardia (if epi used) or transient stimulatory phase.
Conduction Defects: PR prolongation, QRS widening (classic sign), bundle branch blocks.
Dysrhythmias: Bradycardia (most common), VT/VF, PEA, asystole.
Contractility: Profound, refractory hypotension and cardiogenic shock.
IV. Immediate Management Algorithm
Goal: Prevent hypoxia/acidosis and sequester the toxin.
1. Initial Actions
Stop Injection: Immediately halt all LA administration.
Call for Help: Specify βLAST Protocolβ and βIntralipid Kit.β
Airway Management:
100% O2β.
Hyperventilate slightly if needed to counter respiratory acidosis.
Low threshold for intubation (hypoxia/acidosis rapidly worsen LAST).
2. Seizure Control
First-line: Benzodiazepines (e.g., Midazolam).
Avoid: Propofol if hemodynamically unstable (exacerbates cardiac depression).
Neuromuscular Blockers: May be needed for ventilation, but remember they do not stop CNS seizure activity.
3. Lipid Emulsion Therapy 20%
Indications: Start at first sign of serious toxicity (airway compromise, seizures, or CV instability).
Bolus: 1.5...
Duration:00:13:12
Episode 221: High-Output Heart Failure
3/23/2026
We discuss the diagnosis and treatment of one of EM's paradoxes: High-Output Heart Failure.
Hosts:
Nicolas Gonzalez, MD
Brian Gilberti, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/HOHF.mp3
Download Leave a Comment Tags: Cardiology
Show Notes
Core EM Modular CME Course
Maximize your commute with the new Core EM Modular CME Course, featuring the most essential content distilled from our top-rated podcast episodes. This course offers 12 audio-based modules packed with pearls! Information and link below.
Course Highlights:
Credit: 12.5 AMA PRA Category 1 Creditsβ’Curriculum: Comprehensive coverage of Core Emergency Medicine, with 12 modules spanning from Critical Care to Pediatrics.Cost:Free for NYU Learners$250 for Non-NYU Learners Click Here to Register and Begin Module 1
1. Core Definition & Hemodynamic Profile
Clinical Paradox: Congestive symptoms (pulmonary edema, JVD, peripheral edema) in the setting of a hyperdynamic, supranormal cardiac function.
Hemodynamic Criteria:
Cardiac Index (CI): >4.0 L/min/m2.
Cardiac Output (CO): >8 L/min.
Systemic Vascular Resistance (SVR): Pathologically low (vasodilated or shunted state).
The βWarmβ Phenotype: Unlike standard HFrEF/HFpEF (often βCold and Wetβ), HOHF presents as βWarm and Wetβ due to low SVR and bounding pulses.
2. Pathophysiology: The Hemodynamic Paradox
Primary Insult: Decreased SVR (either via peripheral vasodilation or arteriovenous shunting).
Effective Arterial Blood Volume: Paradoxically low despite high total CO.
Neurohormonal Cascade:
Activation of Renin-Angiotensin-Aldosterone System (RAAS).
Increased Sympathetic Nervous System tone.
Increased Antidiuretic Hormone (ADH) secretion.
Resultant State: Avid renal salt and water retention leading to massive plasma volume expansion.
Cardiac Response: Chronic volume overload β eccentric remodeling β chamber dilation β eventual secondary myocardial failure/dilated cardiomyopathy.
3. Differential Diagnosis: Etiological βBucketsβ
Category A: Increased Metabolic Demand (Systemic)
Hyperthyroidism/Thyrotoxicosis:
Direct T3 effects: increased chronotropy/inotropy.
Indirect effects: metabolic byproduct accumulation causing peripheral vasodilation.
Myeloproliferative Disorders:
High cell turnover and increased oxygen consumption drive compensatory CO increase.
Sepsis (Hyperdynamic Phase):
Cytokine-mediated global vasodilation.
Note: Often transient; may transition to sepsis-induced myocardial depression.
Category B: Peripheral Vascular Effects (Shunting/Vasodilation)
Arteriovenous Fistulas (AVF) / Malformations (AVM):
Most Common Cause: Iatrogenic AVF for Hemodialysis (ESRD population).
Bypasses high-resistance capillary beds, dumping arterial blood directly into venous circulation.
Chronic Liver Disease (Cirrhosis):
Formation of βspider angiomataβ and internal AV shunts.
Impaired clearance of endogenous vasodilators (e.g., Nitric Oxide).
Thiamine Deficiency (Wet Beriberi):
Accumulation of pyruvate/lactate β systemic vasodilation.
Histopathology: Vacuolation, myofiber hypertrophy, and interstitial edema.
Chronic Lung Disease:
Hypoxia/Hypercapnia-driven systemic vasodilation.
Concomitant pulmonary HTN (RV remodeling) but preserved/high LV output.
Others: Pagetβs disease of bone (extensive micro-shunting), Carcinoid syndrome, Mitochondrial diseases, Acromegaly, Erythroderma.
4. Special Focus: Hemodialysis Access-Induced HOHF
Physiologic Phases of AVF Creation:
Acute Phase:
Immediate β SVR.
β Stroke volume and Heart Rate (SNS-mediated).
Endothelial shear stress β Nitric Oxide release β further arterial dilation.
Subacute Phase (Days to 2 Weeks):
RAAS-driven volume expansion.
β Right Atrial, Pulmonary Artery, and LV End-Diastolic Pressures (LVEDP).
Natriuretic peptide surge (BNP/ANP) peaks around Day 10.
Chronic Phase (Weeks to Months):
Adaptive hypertrophy.
Decompensation occurs when dilation exceeds contractility limits.
5....
Duration:00:16:28
Episode 220: Post-ROSC Care
3/3/2026
We explore how to refine and optimize care in the vital minutes following ROSC.
Hosts:
Jonathan Elmer, MD, MS
Brian Gilberti, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/Post-ROSC_care.mp3
Download Leave a Comment
Show Notes
Core EM Modular CME Course
Maximize your commute with the new Core EM Modular CME Course, featuring the most essential content distilled from our top-rated podcast episodes. This course offers 12 audio-based modules packed with pearls! Information and link below.
Course Highlights:
Credit: 12.5 AMA PRA Category 1 Creditsβ’Curriculum: Comprehensive coverage of Core Emergency Medicine, with 12 modules spanning from Critical Care to Pediatrics.Cost:Free for NYU Learners$250 for Non-NYU Learners Click Here to Register and Begin Module 1
I. Phase 1: Stabilization (Minutes 0β10)
The βRearrestβ Window & Pathophysiology
High-Risk Period: Rearrest rates reach 30% within the first minutes post-ROSC.
Shock Incidence: Two-thirds of patients develop profound hypotension/shock as initial resuscitative efforts subside.
Catecholamine Washout: Super-physiologic βcode-doseβ epinephrine (1mg IV) typically wears off within ~3 minutes post-ROSC, leading to predictable hemodynamic collapse.
Secondary Injuries: Evaluate for βCPR-induced traumaβ (blunt thoracic trauma, rib fractures, pneumothorax, liver/splenic lacerations).
Immediate Resuscitative Actions
Vascular Access:Transition rapidly from IO to reliable IV access within 1β2 minutes.
Prioritize Intraosseous (IO) placement within 5 minutes if IV attempts fail; intra-arrest data suggests no significant difference in early outcomes.
Vasoactive βBridgeβ:Maintain a βbolus-doseβ pressor at the bedside for immediate push-dose titration.
Options: Phenylephrine, dilute Epinephrine, or dilute Norepinephrine (titrated to effect rather than rigid dosing).
Physician-Specific Task: Arterial Line:Goal: Placement within 5 minutes of ROSC.
Preferred Site: Femoral (by landmarks/blind if necessary) for speed; should be a <2-minute procedure.
Utility: Immediate detection of rearrest and beat-to-beat titration of vasopressors.
II. Phase 2: Diagnostic Workup (Minutes 10β40)
Etiology Epidemiology
ACS Shift: Acute Coronary Syndrome (ACS) is the cause in only 6β10% of resuscitated survivors (lower than historical estimates).
Common Etiologies:Respiratory: COPD, pneumonia, mucus plugging.
Cardiac: Arrhythmia (cardiomyopathy/scar), RV failure (PE), or LV failure.
Neurological: Intracranial hemorrhage (SAH/ICH), status epilepticus (4β5%).
Metabolic: Dialysis-related disarray/hyperkalemia.
Toxicology: Overdose accounts for ~10% of cases in urban centers.
The βBroad Netβ Strategy
βRainbow Labsβ: Comprehensive panel including toxicology and serial biomarkers.
Pan-Scan Protocol:Components: CT/CTA Head/Neck, Contrast CT Chest/Abdomen/Pelvis.
Diagnostic Yield: 50% for clinically significant findings (causes or consequences of arrest).
Contrast Risk: Negligible (1β2% increase in AKI risk) compared to the high diagnostic utility.
Avoid Anchoring: Do not assume ischemic EKG changes are the cause; they are frequently a consequence of the global arrest-induced ischemia.
III. Hemodynamic & Respiratory Targets
Mean Arterial Pressure (MAP)
Autoregulation Shift: In acute brain injury/post-arrest, the lower limit of cerebral autoregulation shifts right, often requiring MAPs of 110β120 mmHg for adequate perfusion.Clinical Target: Aim for MAP >80 mmHg.
The BOX Trial Nuance: While the BOX trial showed no difference between MAP 63 vs. 77, its cohort (Denmark) had exceptionally high survival rates (70% back to work) and short response times, which may not generalize to North American populations with lower shockable rhythm incidence.
Permissive Hypertension: If the patient is βself-drivingβ to higher pressures, do not aggressively lower them, as this may be a physiologic demand for cerebral blood flow.
Ventilation and Oxygenation
PaCO2...
Duration:00:34:09
Episode 219: Meningitis 2.0
2/2/2026
We review diagnosing and managing bacterial meningitis in the ED.
Hosts:
Sarah Fetterolf, MD
Avir Mitra, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/Meningitis_2_0.mp3
Download Leave a Comment Tags: CNS Infections, Infectious Diseases, Neurology
Show Notes
Core EM Modular CME Course
Maximize your commute with the new Core EM Modular CME Course, featuring the most essential content distilled from our top-rated podcast episodes. This course offers 12 audio-based modules packed with pearls! Information and link below.
Course Highlights:
Credit: 12.5 AMA PRA Category 1 Creditsβ’Curriculum: Comprehensive coverage of Core Emergency Medicine, with 12 modules spanning from Critical Care to Pediatrics.Cost:Free for NYU Learners$250 for Non-NYU Learners Click Here to Register and Begin Module 1
Patient Presentation & Workup
CSF Analysis & Microbiology
Bacterial MeningitisOpening Pressure:<170H2βOColor:Gram Stain:60%β80%7%β41%Cell Count:>10002000/mm3>80%Glucose:<40<0.30.4Protein:>200Cytology:Viral MeningitisOpening Pressure:Color:Gram Stain:Cell Count:<300/mm3<20%Glucose:Protein:<200Cytology:Fungal MeningitisOpening Pressure:Color:Gram Stain:Cell Count:<500/mm3Glucose:Protein:>200Cytology:Neoplastic (Cancer-related) MeningitisOpening Pressure:Color:Gram Stain:Cell Count:<300/mm3Glucose:Protein:>200Cytology:Positive
Management Protocol
Stats & Clinical Pearls: Austrian Syndrome
Read More
Duration:00:15:33
Episode 218: Sympathetic Crashing Acute Pulmonary Edema (SCAPE)
1/16/2026
We discuss the diagnosis and management of SCAPE in the ED.
Hosts:
Naz Sarpoulaki, MD, MPH
Brian Gilberti, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/SCAPE.mp3
Download Leave a Comment Tags: Acute Pulmonary Edema, Critical Care
Show Notes
Core EM Modular CME Course
Maximize your commute with the new Core EM Modular CME Course, featuring the most essential content distilled from our top-rated podcast episodes. This course offers 12 audio-based modules packed with pearls! Information and link below.
Course Highlights:
Credit: 12.5 AMA PRA Category 1 Creditsβ’Curriculum: Comprehensive coverage of Core Emergency Medicine, with 12 modules spanning from Critical Care to Pediatrics.Cost:Free for NYU Learners$250 for Non-NYU Learners Click Here to Register and Begin Module 1
The Clinical Case
Presentation: 60-year-old male with a history of HTN and asthma.EMS Findings: Severe respiratory distress, SpOβ in the 60s on NRB, HR 120, BP 230/180.Exam: Diaphoretic, diffuse crackles, warm extremities, pitting edema, and significant fatigue/work of breathing.Pre-hospital meds: NRB, Duonebs, Dexamethasone, and IM Epinephrine (under the assumption of severe asthma/anaphylaxis). Differential Diagnosis for the Hypoxic/Tachypneic Patient
Pulmonary: Asthma/COPD, Pneumonia, ARDS, PE, Pneumothorax, Pulmonary Edema, ILD, Anaphylaxis.Cardiac: CHF, ACS, Tamponade.Systemic: Anemia, Acidosis.Neuro: Neuromuscular weakness. What is SCAPE?
Sympathetic Crashing Acute Pulmonary Edema (SCAPE) is characterized by a sudden, massive sympathetic surge leading to intense vasoconstriction and a precipitous rise in afterload.
Pathophysiology: Unlike HFrEF, these patients are often euvolemic or even hypovolemic. The primary issue is fluid maldistribution (fluid shifting from the vasculature into the lungs) due to extreme afterload. Bedside Diagnosis: POCUS vs. CXR
POCUS is the gold standard for rapid bedside diagnosis.
Lung Ultrasound: Look for diffuse B-lines (β₯3 in β₯2 bilateral zones).Cardiac: Assess LV function and check for pericardial effusion.Why not CXR? A meta-analysis shows LUS has a sensitivity of ~88% and specificity of ~90%, whereas CXR sensitivity is only ~73%. Importantly, up to 20% of patients with decompensated HF will have a normal CXR. Management Strategy
1. NIPPV (CPAP or BiPAP)
Start NIPPV immediately to reduce preload/afterload and recruit alveoli.
Settings: CPAP 5β8 cm HβO or BiPAP 10/5 cm HβO. Escalate EPAP quickly but keep pressures to avoid gastric insufflation.Evidence: NIPPV reduces mortality (NNT 17) and intubation rates (NNT 13). 2. High-Dose Nitroglycerin
The goal is to drop SBP to < 140β160 mmHg within minutes.
No IV Access: 3β5 SL tabs (0.4 mg each) simultaneously.IV Bolus: 500β1000 mcg over 2 minutes.IV Infusion: Start at 100β200 mcg/min; titrate up rapidly (doses > 800 mcg/min may be required).Safety: ACEP policy supports high-dose NTG as both safe and effective for hypertensive HF. Use a dedicated line/short tubing to prevent adsorption issues. 3. Refractory Hypertension
If SBP remains > 160 mmHg despite NIPPV and aggressive NTG, add a second vasodilator:
Clevidipine: Ultra-short-acting calcium channel blocker (titratable and rapid).Nicardipine: Effective alternative for rapid BP control.Enalaprilat: Consider if the above are unavailable. Troubleshooting & Pitfalls
The βMask Intolerantβ Patient
Hypoxia is the primary driver of agitation. NIPPV is the best sedative. * Pharmacology: If needed, use small doses of benzodiazepines (Midazolam 0.5β1 mg IV).
AVOID Morphine: Data suggests higher rates of adverse events, invasive ventilation, and mortality. A 2022 RCT was halted early due to harm in the morphine arm (43% adverse events vs. 18% with midazolam). The Role of Diuretics
In SCAPE, diuretics are not first-line.
The problem is redistribution, not volume excess. Diuretics will not help in the first 15β30 minutes and may worsen kidney function in a (relatively)...
Duration:00:12:45
Episode 217: Prehospital Blood Transfusion
1/1/2026
We discuss the shift to prehospital blood to treat shock sooner.
Hosts:
Nichole Bosson, MD, MPH, FACEP
Avir Mitra, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/Prehospital_Transfusion.mp3
Download Leave a Comment Tags: EMS, Prehospital Care, Trauma
Show Notes
Core EM Modular CME Course
Maximize your commute with the new Core EM Modular CME Course, featuring the most essential content distilled from our top-rated podcast episodes. This course offers 12 audio-based modules packed with pearls! Information and link below.
Course Highlights:
Credit: 12.5 AMA PRA Category 1 Creditsβ’Curriculum: Comprehensive coverage of Core Emergency Medicine, with 12 modules spanning from Critical Care to Pediatrics.Cost:Free for NYU Learners$250 for Non-NYU Learners Click Here to Register and Begin Module 1
What is prehospital blood transfusion
Administration of blood products in the field prior to hospital arrival
Aimed at patients in hemorrhagic shock
Why this matters
Traditional US prehospital resuscitation relied on crystalloid
ED and trauma care now prioritize early blood
Hemorrhage occurs before hospital arrival
Delays to definitive hemorrhage control are common
Earlier blood may improve survival
Supporting rationale
ATLS and trauma paradigms emphasize blood over fluid
National organizations support prehospital blood when feasible
EMS already manages high risk, time sensitive interventions
Evidence overview
Data are mixed and evolving
COMBAT: no benefit
PAMPer: mortality benefit
RePHILL: no clear benefit
Signal toward benefit when transport time exceeds ~20 minutes
Urban systems still experience long delays due to traffic and geography
LA County median time to in hospital transfusion ~35 minutes
LA County program
~2 years of planning before launch
Pilot began April 1
Partnerships:
LA County Fire
Compton Fire
Local trauma centers
San Diego Blood Bank
14 units of blood circulating in the field
Blood rotated back 14 days before expiration
Ultimately used at Harbor UCLA
Continuous temperature and safety monitoring
Indications used in LA County
Focused rollout
Trauma related hemorrhagic shock
Postpartum hemorrhage
Physiologic criteria:
SBP < 70
Or HR > 110 with SBP < 90
Shock index β₯ 1.2
Witnessed traumatic cardiac arrest
Products:
One unit whole blood preferred
Two units PRBCs if whole blood unavailable
Early experience
~28 patients transfused at time of discussion
Evaluating:
Indications
Protocol adherence
Time to transfusion
Early outcomes
Too early for outcome conclusions
California collaboration
Multiple active programs:
Riverside (Corona Fire)
LA County
Ventura County
Additional programs planned:
Sacramento
San Bernardino
Programs meet monthly as CalDROP
Focus on shared learning and operational optimization
Barriers and concerns
Trauma surgeon concerns about blood supply
Need for system wide buy in
Community engagement
Patients who may decline transfusion
Women of childbearing age and alloimmunization risk
Risk of HDFN is extremely low
Clear communication with receiving hospitals is essential
Future direction
Rapid national expansion expected
Greatest benefit likely where transport delays exist
Prehospital Blood Transfusion Coalition active nationally
Major unresolved issue: reimbursement
Currently funded largely by fire departments
Sustainability depends on policy and payment reform
Take-Home Points
Hemorrhagic shock is best treated with blood, not crystalloid
Prehospital transfusion may benefit patients with prolonged transport times
Implementation requires strong partnerships with blood banks and trauma centers
Early data are promising, but patient selection remains critical
National collaboration is key to sustainability and future growth
Read More
Duration:00:13:03
Episode 216: BRUE (Brief Resolved Unexplained Event)
12/1/2025
We review BRUEs (Brief Resolved Unexplained Events).
Hosts:
Ellen Duncan, MD, PhD
Noumi Chowdhury, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/BRUE.mp3
Download Leave a Comment Tags: Pediatrics
Show Notes
What is a BRUE?
Cyanosis or pallor
Irregular, absent, or decreased breathing
Marked change in tone (hypertonia or hypotonia)
Crucial Caveat: BRUE is a diagnosis of exclusion. If the history and physical exam reveal a specific cause (e.g., reflux, seizure, infection), it is not a BRUE.
Risk Stratification: Low Risk vs. High Risk
Risk stratification is the most important step in management. While only 6-15% of cases meet strict βLow Riskβ criteria, identifying these patients allows us to avoid unnecessary invasive testing.
Low Risk Criteria
To be considered Low Risk, the infant must meet ALL of the following:
Age: > 60 days old
Gestational Age: GA > 32 weeks (and Post-Conceptional Age > 45 weeks)
Frequency: This is the first episode
Duration: Lasted < 1 minute
Intervention: No CPR performed by a trained professional
Clinical Picture: Reassuring history and physical exam
Management for Low Risk:
Generally do not require extensive testing or admission.
Prioritize safety education/anticipatory guidance.
Ensure strict return precautions and close outpatient follow-up (within 24 hours).
High Risk Criteria
Any infant not meeting the low-risk criteria is automatically High Risk.
Additional red flags include:
Suspicion of child abuse
History of toxin exposure
Family history of sudden cardiac death
Abnormal physical exam findings (trauma, neuro deficits)
Management for High Risk:
Requires a more thorough evaluation.
Often requires hospital admission.
Note: Differential Diagnosis: βTHE MISFITSβ Mnemonic
T β Trauma (Accidental or Non-accidental/Abuse)
H β Heart (Congenital heart disease, dysrhythmias)
E β Endocrine
M β Metabolic (Inborn errors of metabolism)
I β Infection (Sepsis, meningitis, pertussis, RSV)
S β Seizures
F β Formula (Reflux, allergy, aspiration)
I β Intestinal Catastrophes (Volvulus, intussusception)
T β Toxins (Medications, home exposures)
S β Sepsis (Systemic infection)
Workup & Diagnostics
Step 1: Stabilization
ABCs (Airway, Breathing, Circulation)
Point-of-care Glucose
Cardiorespiratory monitoring
Step 2: Diagnostic Testing (For High Risk/Symptomatic Patients)
Labs: VBG, CBC, Electrolytes.
Imaging:
CXR: Evaluate for infection and cardiothymic silhouette.
EKG: Evaluate for QT prolongation or dysrhythmias.
Neuro: Clinical Pearl: Only ~6% of diagnostic tests contribute meaningfully to the diagnosis. Be judiciousβavoid βshotgunningβ tests in low-risk patients.
Prognosis & Outcomes
Recurrence: Approximately 10% (lower than historical ALTE rates of 10-25%).
Mortality: < 1%. Nearly always linked to an identifiable cause (abuse, metabolic disorder, severe infection).
BRUE vs. SIDS: These are not the same.
BRUE: Peaks < 2 months; occurs mostly during the day.
SIDS: Peaks 2β4 months; occurs mostly midnight to 6:00 AM.
Take-Home Points
Diagnosis of Exclusion: You cannot call it a BRUE until you have ruled out obvious causes via history and physical.
Strict Criteria: Stick strictly to the Low Risk criteria guidelines. If they miss even one (e.g., age < 60 days), they are High Risk.
Education: For low-risk families, the most valuable intervention is reassurance, education, and arranging close follow-up.
Systematic Approach: For high-risk infants, use a structured approach (like THE MISFITS) to ensure you donβt miss rare but reversible causes.
Read More
Duration:00:04:31
Episode 215: Marburg Virus and Global EM
11/1/2025
Lessons from Rwandaβs Marburg Virus Outbreak and Building Resilient Systems in Global EM.
Hosts:
Tsion Firew, MD
Brian Gilberti, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/Marburg_Virus.mp3
Download Leave a Comment Tags: Global Health, Infectious Diseases
Show Notes
Context and the Rwanda Marburg Experience
The Threat: Marburg Virus Disease is from the same family as Ebola and has historically had a reported fatality rate as high as 90%.
The Outbreak (Sept. 2024): Rwanda declared an MVD outbreak. The initial cases involved a miner, his pregnant wife (who fell ill and died after having a baby), and the baby (who also died).
Healthcare Worker Impact: The wife was treated at an epicenter hospital. Eight HCWs were exposed to a nurse who was coding in the ICU; all eight developed symptoms, tested positive within a week, and four of them died.
The Turning Point: The outbreak happened in city referral hospitals where advanced medical interventions (dialysis, mechanical ventilation) were available.
Rapid Therapeutics Access: Within 10 days of identifying Marburg, novel therapies (experimental drugs and monoclonal antibodies) and an experimental vaccine were made available through diplomacy with the US government/CDC and agencies like WHO, Africa CDC, CEPI and more.
The Outcome: This coordinated effortβcombini...
Duration:00:11:17
Episode 214: Acute Pulmonary Embolism
10/1/2025
We review the diagnosis, risk stratification, & management of acute pulmonary embolism in the ED.
Hosts:
Vivian Chiu, MD
Brian Gilberti, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/Acute_Pulmonary_Embolism.mp3
Download Leave a Comment Tags: Pulmonary
Show Notes
Core Concepts and Initial Approach
Definition:DVTIncidence & Mortality:Mantra:risk stratifyresuscitate with precisionRisk Factors:
Clinical Presentation and Risk Stratification
Presentation:Acute/Subacute:DyspneaChronic:Pulmonary Infarction Signs:High-Risk Red Flags:hypotension
Duration:00:15:38
Episode 213: Pneumothorax
9/1/2025
We break down pneumothorax: risks, diagnosis, and management pearls.
Hosts:
Christopher Pham, MD
Brian Gilberti, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/Pneumothorax.mp3
Download Leave a Comment Tags: Chest Trauma, Pulmonary, Trauma
Show Notes
Risk Factors for Pneumothorax
Secondary pneumothoraxPrimary spontaneous pneumothorax
Symptoms & Differential Diagnosis
Diagnostics
Bloodwork:EKG:
Duration:00:14:27
Episode 212: Angioedema
8/1/2025
Angioedema β Recognition and Management in the ED
Hosts:
Maria Mulligan-Buckmiller, MD
Brian Gilberti, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/Angioedema.mp3
Download Leave a Comment Tags: Airway
Show Notes
Definition & Pathophysiology
Angioedema = localized swelling of mucous membranes and subcutaneous tissues due to increased vascular permeability.
Triggers increased vascular permeability β fluid shifts into tissues.
Etiologies
Histamine-mediated (anaphylaxis)Bradykinin-mediatedIdiopathic angioedema
Clinical Presentations
SwellingRespiratory compromiseAbdominal manifestations
Duration:00:13:05
Episode 211: Granulomatosis with Polyangiitis
7/1/2025
Granulomatosis with Polyangiitis (GPA) β Recognition and Management in the ED
Hosts:
Phoebe Draper, MD
Brian Gilberti, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/GPA.mp3
Download Leave a Comment Tags: Rheumatology
Show Notes
Background
Red Flag Symptoms:
Workup in the ED:
Management:
Stable patients:Unstable patients: Conditions that Mimic GPA:
Duration:00:09:02
Episode 210: Capacity Assessment
6/1/2025
We discuss capacity assessment, patient autonomy, safety, and documentation.
Hosts:
Anne Levine, MD
Brian Gilberti, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/Capacity_Assessment.mp3
Download Leave a Comment
Show Notes
The Importance of Capacity Assessment
Defining Capacity
Real-World ED Examples
The 4 Pillars of Capacity Assessment
UnderstandingSample prompts:
Duration:00:09:56
Episode 209: Blast Crisis
5/1/2025
We dive into the recognition and management of blast crisis.
Hosts:
Sadakat Chowdhury, MD
Brian Gilberti, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/Blast_Crisis.mp3
Download Leave a Comment Tags: Hematology, Oncology
Show Notes
Topic Overview
Pathophysiology & Associated Conditions
Risk Factors
Clinical Presentation
Episode 208: Geriatric Emergency Medicine
4/15/2025
We explore the expanding field of Geriatric Emergency Medicine.
Hosts:
Ula Hwang, MD
Brian Gilberti, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/Geriatric_Emergency_Medicine.mp3
Download Leave a Comment Tags: Geriatric
Show Notes
Key Topics Discussed
Challenges in Geriatric Emergency Care
Adapting Clinical Approach
Identifying High-Risk Geriatric Patients
Episode 207: Smoke Inhalation Injury
4/1/2025
We discuss the injuries sustained from smoke inhalation.
Hosts:
Sarah Fetterolf, MD
Brian Gilberti, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/Smoke_Inhalation.mp3
Download Leave a Comment Tags: Environmental, Toxicology
Show Notes
Table of Contents
00:37 β Overview of Smoke Inhalation Injury
00:55 β Three Key Pathophysiologic Processes
01:41 β Physical Exam Findings to Watch For
02:12 β Airway Management and Early Intervention
03:23 β Carbon Monoxide Toxicity
04:24 β Workup and Initial Treatment of CO Poisoning
06:14 β Cyanide Toxicity
07:19 β Treatment Options for Cyanide Poisoning
09:12 β Take-Home Points and Clinical Pearls
Physiological Effects of Smoke Inhalation:
Thermal Injury:Chemical Irritation:Systemic Toxicity:
Episode 206: Acute Back Pain
3/3/2025
We discuss the evaluation of and treatment options for acute back pain.
Hosts:
Benjamin Friedman, MD
Brian Gilberti, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/Acute_Back_Pain.mp3
Download Leave a Comment Tags: Musculoskeletal, Orthopaedics
Show Notes
**Please fill out this quick survey to help us develop additional resources for our listeners: Core EM Survey**
Clinical Evaluation:
Primary Goal:Red Flags: Assessment:Additional Tools: Imaging Guidelines:
Routine Imaging:ACEP Recommendations:Advanced Imaging: Treatment Options:
Evidence-Based First-Line:
Duration:00:17:15
Episode 205: Family Presence during Resuscitation
2/2/2025
We discuss the impact of family presence during resuscitations.
Hosts:
Ellen Duncan, MD, PhD
Brian Gilberti, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/Family_Presence_During_Resuscitation.mp3
Download Leave a Comment Tags: Critical Care, Pediatrics
Show Notes
Overview
Historical Context:Current Practices in Pediatrics:Common Concerns & Myths: Evidence from the Literature
New England Journal of Medicine study on Family Presence During Cardiopulmonary Resuscitation (Jabre et al., 2013):
Duration:00:03:26
Episode 204: Necrotizing Fasciitis
1/1/2025
We discuss the recognition and treatment of necrotizing fasciitis.
Hosts:
Aurnee Rahman, MD
Brian Gilberti, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/Necrotizing_Fasciitis.mp3
Download Leave a Comment Tags: Critical Care, General Surgery
Show Notes
Table of Contents
0:00 β Introduction
0:41 β Overview
1:10 β Types of Necrotizing Fasciitis
2:21 β Pathophysiology & Risk Factors
3:16 β Clinical Presentation
4:06 β Diagnosis
5:37 β Treatment
7:09 β Prognosis and Recovery
7:37 β Take Home points
Introduction
Definition
Types of Necrotizing Fasciitis
Type I (Polymicrobial)
Duration:00:06:28
Episode 203: Acetaminophen Toxicity
12/2/2024
We sit down with one of our toxicologists to discuss acetaminophen toxicity.
Hosts:
Marlis Gnirke, MD
Brian Gilberti, MD
https://media.blubrry.com/coreem/content.blubrry.com/coreem/Acetaminophen_Toxicity.mp3
Download Leave a Comment Tags: Toxicology
Show Notes
Table of Contents
0:35 β Hidden acetaminophen toxicity in OTC products
3:24 β Pharmacokinetics and toxicokinetics
6:06 β Clinical Course
9:22 β The antidote β NAC
11:02 β The Rumack-Matthew Nomogram
17:36 β Treatment protocols
22:34 β Monitoring and Lab Work
23:23 β Considerations when treating pediatric patients
23:57 β IV APAP overdose, fomepizole
25:42 β Take Home Points
Acetaminophen vs. Tylenol:
The importance of recognizing that acetaminophen is found in many products beyond Tylenol.Common medications containing acetaminophen, such as Excedrin, Fioricet, Percocet, Dayquil/Nyquil, and others.The risk of unintentional overdose due to combination products. Prevalence of Acetaminophen Toxicity:
Duration:00:27:21